New Jersey’s First Liver Transplant Center is National Leader in Three-Year Survival Rates
The University Hospital Center for Advanced Liver Diseases and Transplantation, led by the nationally recognized physicians at Rutgers New Jersey Medical School (NJMS), has been ranked by The Scientific Registry of Transplant Recipients (SRTR) as the national leader in three-year survival rates for liver transplant programs across the country. The Newark-based Center ranks ahead of a number of other skilled centers that perform at least 10 transplant procedures within a 12-month span and covers survival rates for transplant procedures performed from July 1, 2017-December 21, 2019.
With an estimated three-year survival rate of 98.72%, the Center for Advanced Liver Diseases and Transplantation was rated as the top center of its kind in the country. University Hospital edged out its peers at Montefiore Medical Center in New York City and is notably ahead of institutions such as Colombia University Irving Medical Center, The Cleveland Clinic, John Hopkins Hospital and Mt. Sinai Health System.
“We are excited to report our outstanding three-year outcomes after liver transplantation. We congratulate every member of our team for their incredible dedication in delivering patient-centered care and innovation to transplant candidates and recipients who face their illness with tremendous courage and strength,” said Dr. James V. Guarrera, Professor and Chief of Transplant and Hepatobiliary Surgery at NJMS and Program Director of University Hospital’s Liver Transplant Program. “We must also thank all of our organ donors and families for making transplantation possible with their selfless gifts of life.”
The Center for Advanced Liver Diseases and Transplantation at UH, under the guidance of skilled physicians from Rutgers New Jersey Medical School, is the first such center in New Jersey and one of 61 centers nationally. Since it opened in 1989, the center has performed more than 1,650 liver transplant surgeries, including nearly 80 transplants in the last two years alone. The SRTR, operated by the Chronic Disease Research Group, a division of the Hennepin Healthcare Research Institute, is a federally supported program under contract from the Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration (HRSA), US Department of Health and Human Services (HHS). Innovation and research are at the core of its mission, from groundbreaking work in the field of liver transplant preservation, to being the highest global enroller of patients in multiple transplant hepatology studies.
“Having the top liver transplant survival rates in the nation validates our belief that University Hospital is the preeminent academic medical center in New Jersey. It also endorses the Center for Advanced Liver Diseases and Transplantation as another point of pride for the institution,” said Ed Jimenez, President and CEO of University Hospital. “The SRTR ranking broadens our profile and enhances the awareness of University Hospital, and our partners at Rutgers New Jersey Medical School, to the larger world. Lives are literally being saved because of the Center for Advanced Liver Diseases and Transplantation, the leadership of Drs. Guarrera and Pyrsopoulos, our dedicated team members, and the active support of our partners at Rutgers New Jersey Medical School.”
“The stellar three-year survival rate is a testament to our multidisciplinary approach to transplantation. We are treating patients whose only hope of survival is receiving a liver transplant,” said Dr. Nikolaos Pyrsopoulos, Professor of Medicine and Director of Gastroenterology and Hepatology at NJMS and Medical Director of Liver Transplant for University Hospital. “The dedication and the exciting innovations in care that our team is offering to these patients and our community at Rutgers New Jersey Medical School and University Hospital is second to none.”
The Minnesota-based SRTR supports the transplant community with studies and evaluations of institutional transplant performance to better patient results and experience. Through the evaluation of national data collected by the Organ Procurement and Transplant Network (OPTN) on transplant programs and organ procurement organizations, their program-specific reports provide wide-ranging information about transplant programs and their results. Improving patient outcomes is their number one goal.
The SRTR is also a trusted resource for epidemiological data and statistical analysis regarding the status of solid organ transplantation and the transplantation system in the United States. It seeks to provide information that is accurate, clear, and timely for use by the public, the Department of Health and Human Services, the OPTN/United Network for Organ Sharing, transplant programs, organ procurement organizations, transplant candidates, transplant recipients, living donors, and donor families.